TRIGGER
CLOSED
Electronic platform to pelvic cancer patients
Trigger aimed to look at side effects in patients with pelvic cancer receiving curative radiotherapy using a simple screening tool, hosted onto an independent secure platform. Patients enrolled at the end of their treatment and entered their name and date of birth, email address, and information about their cancer and treatment end-date. They answered their first questionnaire at enrolment and received a reminder every three months post-treatment to capture the evolution of their side effects. If they experienced significant side effects, they saw a phone number to contact their team, to discuss the symptoms and to decide if an appointment was necessary. Patients could answer the questionnaires as often as they desired, for how long they wished.